Errors in the management of regular medications at the time of hospital admission are common. This may result in clinically important patient discomfort or deterioration 1 . Medication errors, discrepancies and omissions also have the potential to be continued on discharge, resulting in unintended changes to patients' long-term medications and possible adverse outcomes.
A recent study looking at postoperative prescribing showed that unintentional omission of regular medicines was the most common postoperative medication discrepancy, occurring in as many as 47% of patients. Pharmacist medication history taking in the pre-admission clinic reduced this rate to 37% 2 .
A small prospective study in patients undergoing surgery also identified that only 71% of patients receiving regular medication for cardiovascular disease had these medications prescribed before surgery and 41% had unintended missed doses on the day of surgery 3 . A more recent study in internal medicine patients indicated that for patients on four or more medicines, as many as 46% had an unintended medication omission, with 40% of these judged to have the potential to cause moderate to severe discomfort or deterioration 1 . Other more recent studies also identified medication discrepancies as an issue 4 . The problem thus appears to persist despite considerable change in practice models over time.
This study was prompted by a desire to improve the quality and safety of the management of patients' regular medication during the perioperative period. The aim was to measure the effect of pharmacist involvement in medication history taking and supplementary prescribing in the perioperative setting.
A randomised controlled trial of pharmacist medication histories and supplementary prescribing on medication errors in postoperative medications S. B. MAROTTI*, R. K. KERRIDGE †, M. D. GRIMER ‡ Perioperative Service, John Hunter Hospital, Newcastle, New South Wales, Australia SUMMARY Errors in the management of regular medications at the time of hospital admission are common. This randomised controlled three-arm parallel-group trial examined the impact of pharmacist medication history taking and pharmacist supplementary prescribing on unintentional omissions of postoperative medications in a large perioperative service. Participants included elective surgical patients taking regular medications with a postoperative hospital stay of one night or more. Patients were randomly assigned, on admission, to usual care (n=120), a pharmacist medication history only (n=120) or pharmacist medication history and supplementary prescribing (n=120). A medication history involved the pharmacist interviewing the patient preoperatively and documenting a medication history in the medical record. In the supplementary prescribing group the patients' regular medicines were also prescribed on the inpatient medication chart by the pharmacist, so that dosing could proceed as soon as possible after surgery without the need to wait for medical review. The estimate marginal mean number of missed doses during a patients hospital stay was 1.07 in the pharmacist supplementary prescribing group, which was significantly less than both the pharmacist history group (3.30) and the control group (3.21) (P <0.001). The number of medications charted at an incorrect dose or frequency was significantly reduced in the pharmacist history group and further reduced in the prescribing group (P <0.001). We conclude that many patients miss doses of regular medication during their hospital stay and preoperative medication history taking and supplementary prescribing by a pharmacist can reduce this.
METHODS
John Hunter Hospital is a 750-bed regional tertiary referral hospital in Newcastle, New South Wales. Approximately 92% of elective surgery patients staying at least one night are admitted on the day of surgery. Higher risk patients (approximately 62% of all surgical patients who stay at least one night) are seen by a nurse and a doctor in a preoperative assessment and preparation clinic before admission. Information about a patient's medicines is collected and recorded in the medical record, but is not prescribed on the medication chart before admission. On the day of surgery, all elective surgery patients come through a centralised preoperative area, arriving approximately two hours prior to surgery. In most instances, the patients' medications are charted postoperatively, when limited information is available regarding their drugs and doses and the prescriber is unfamiliar with the patient.
This study was a randomised, three-arm, prospective, parallel group trial. All adult elective surgery patients admitted to the John Hunter Hospital on the day of surgery were candidates for inclusion in the study. Surgery types included general, cardiothoracic, gynaecology, vascular, urology, ear nose and throat, facio-maxillary and transplant surgery. Orthopaedic surgery patients were excluded due to local process differences. Patients were excluded from the trial if they took no regular medications, were unable to provide consent, had medications charted during a preoperative clinic visit or were admitted as a day-only patient.
Our primary aim was to determine whether the number of missed doses of regular medication were significantly different between one of three allocated interventions: 1) usual care (control), 2) preoperative pharmacist medication history only, and 3) preoperative pharmacist medication history and supplementary prescribing on the day of surgery. Subgroup analysis was performed for several medication groups (beta blockers, 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors, antiplatelets and anticoagulants) due to the possible clinical implications that missed doses of these medications may have [5] [6] [7] [8] [9] . Limited data exist on the incidence of missed medication doses in this patient population, making a formal power calculation based on our primary outcome measure unfeasible. A sample size of 360 was chosen; however it was recognised that this sample size would be unlikely to detect a statistical or clinical difference in any of the secondary outcome measures.
The study protocol was approved by the Hunter New England Human Research Ethics Committee.
The New South Wales Department of Health
Pharmaceutical Services Branch approved pharmacist supplementary prescribing for the purposes of this research.
INTERVENTIONS
Patients were randomised to receive either usual care (control), a pharmacist medication history only or a pharmacist both taking the history and prescribing medications on their medication chart. 'Usual care' involved no clinical pharmacist consultation prior to surgery. These patients had their medications charted immediately prior to surgery or postoperatively by the medical officer in the normal time frame. New medications required perioperatively were charted by a medical officer in the usual way, for all three groups.
For patients in both intervention groups, the pharmacist interviewed patients at the time of admission on the day of surgery and documented a regular medication list. For patients randomised to supplementary pharmacist prescribing, the pharmacist also prescribed their regular medicines on the medication chart. Pharmacist prescribing was guided by protocols advising which medications should be withheld and for how long, for each type of surgery. These were developed before the study in consultation with surgeons and anaesthetists and approved by the hospital's drug and therapeutics committee. Where patients did not fit the protocol, prescribing was guided by discussion with the patient's medical team.
OUTCOME MEASURES
The primary hypothesis was that pharmacist supplementary prescribing of regular medications preoperatively reduces the number of medication doses missed inappropriately during the inpatient stay. Secondary hypotheses were that pharmacist supplementary prescribing reduces the number of medications charted at an incorrect dose or frequency and reduces the number of missed medication doses postoperatively of significant medications such as beta blockers, 3-hydroxy-3methyl-glutaryl-CoA reductase inhibitors, antiplatelets and anticoagulants.
RANDOMISATION
Patients were randomised via a computergenerated list, held by an independent investigator to ensure allocation concealment. Randomisation was done in permuted blocks of 60 to ensure balance of numbers in each group at any time during the trial. After identifying patients suitable for inclusion in the trial, the trial pharmacist obtained written informed consent prior to randomisation.
PROCEDURES
Outcome measures were collected after discharge by an independent technician through retrospective chart review and patient administration system records. In all three groups the patient's regular medication list was compared with their inpatient medication chart to determine number of missed doses during their inpatient stay. Comparisons were based on hospital protocols for regular medication management. Decisions to change medicines and cease medicines that were clearly documented were also taken into consideration.
In the control group the patient's regular medication list was obtained from the patient post discharge by the trial pharmacist over the phone. A combination of the preoperative questionnaire filled out by the patient, the admission and progress notes and lists faxed from the community pharmacy and community doctor were used to prompt the patient on their regular medication prior to admission. The final list was then used as the patient's regular medication list for the purpose of comparison with their inpatient orders.
STATISTICAL ANALYSIS
All data analysis was carried out according to pre-established criteria using statistical software PASW 18.0 (SPSS Inc., Chicago, IL, USA). Generalised linear models were used to assess if there was an effect due to group, with post hoc comparisons of estimated marginal means used to determine where differences between groups were occurring. For the total number of missed doses per patient, Poisson log-linear methods were used with maximum possible number of doses as a covariate. Poisson log-linear methods were also used for number of medications charted at a different dose or different frequency with total number of regular medications as a covariate. Planned sub-group analyses for missed doses of beta blockers, 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors, anti-platelets and anticoagulants were analysed using Poisson log-linear methods, with length of hospital stay as a covariate. For all other count data, Poisson log-linear models (with no covariates) were used and for dichotomous outcomes, a binary logit model was used. Results are reported as estimated marginal means with 95% confidence intervals (CI) calculated from the generalised linear models. Results were considered significant at α=0.05.
RESULTS
Between November 2008 and March 2009, 357 patients were randomised to one of three interventions ( Figure 1) ; usual care (n=118), pharmacist medication history on admission (n=119) and pharmacist history and supplementary prescribing of regular medications (n=120). Three patients were excluded at randomisation as they had previously been enrolled in the trial and were to be analysed in their original randomisation group. Two (0.5%) patients were lost to follow-up, as the notes could not be obtained. Median number of hospital admissions in the previous 12 months,
Median number of regular medications prior to admission, (IQR)* 4 (2-7) 4 (2-5) 5 (3-7)
Values are number (%) unless stated otherwise. * Data collected only for patients who underwent surgery. IQR=interquartile range.
All data were analysed using intention-to-treat. The pharmacist was unable to provide the intervention for one patient in group three. Patients who had their surgery cancelled were included in the analysis to determine proportions of cancelled operations but were excluded from the remainder of analysis as these patients had no postoperative data (Figure 1 109 in the pharmacist history group and 112 in the pharmacist prescribing group remained for analysis. Baseline characteristics were well balanced between the groups (Table 1 ) and were not adjusted for or used as a covariate for any of the analyses. The estimated marginal mean number of missed doses per patient during hospital stay was 3.21 (95% CI 2.89 to 3.52) in the control group, which was significantly reduced in the pharmacist prescribing group (1.07, 95% CI 0.9 to 1.25) (P=0.002), but not the pharmacist history group (3.30, 95% CI 2.98 to 3.63) ( Table 2 ). This important finding shows that obtaining and documenting a medication history does not significantly change the number of missed doses, unless a process change is implemented ensuring medications are prescribed preoperatively.
The number of medications charted at an incorrect dose was significantly reduced in the pharmacist history group and pharmacist prescribing group (P <0.001), with the pharmacist prescribing group having even less dose errors than the pharmacist history group (P=0.004). The number of medications charted at an incorrect frequency was significantly reduced in the pharmacist history group and pharmacist prescribing group (P <0.001).
DISCUSSION
Supplementary pharmacist prescribing immediately preoperatively reduced the number of missed regular medication doses postoperatively. Pharmacist prescribing also reduced the incidence of errors related to dose and frequency of medications. A pharmacist taking and documenting a medication history alone was inferior to pharmacist prescribing, possibly because there are a number of factors preand postoperatively that prevent regular medicines being prescribed appropriately even when a detailed and accurate medication history is documented. While taking a medication history had no effect on missed doses, it is interesting to note that documentation of an accurate medication history did significantly reduce the number of prescribing errors even if it was not the pharmacist prescribing the medications.
Errors in the management of regular medications may arise in association with medication history taking, inappropriate decision-making about management of regular medication or errors in prescribing (charting) of regular medication. Medication reconciliation upon admission to hospital has been shown to reduce medication errors [10] [11] [12] . This requires the patient to be interviewed comprehensively, with documentation of a full medication list and use of this list when writing medication orders 13, 14 . There have also been several studies looking at prescribing errors which have identified inattention, lack of knowledge, communication problems and lack of familiarity with the patient as being contributory factors [15] [16] [17] .
Pharmacists are trained to take a medication history from a patient. In studies in the USA, this resulted in fewer discrepancies than history taking by physicians 18, 19 . In a number of centres across Australia it has become standard practice for pharmacists to write medication charts in the pre-admission clinic that are then authorised by a medical officer. A study looking at pharmacist charting of regular medicines in the emergency department has also been shown to reduce medication discrepancies 20 . However, the role of the pharmacist in taking a medication history and charting the medications for administration without a requirement for final medical authorisation is novel role and has not been studied.
Non-medical prescribing is an area that is rapidly developing. Pharmacist prescribing has become common practice in the United Kingdom in the last seven years, with development of the pharmacist as an independent and supplementary prescriber. In the United Kingdom, an independent pharmacist prescriber is responsible and accountable for the assessment of patients with undiagnosed and diagnosed conditions and for decisions about the clinical management including prescribing within their area of competence. In contrast, a supplementary pharmacist prescriber is restricted to prescribing medicines that are either established treatments for that patient or those under individual treatment plans. These are informed by clinical guidelines to make changes or adjustments to these medicines.
While much has been published about the views of patients and prescribers on the role of the pharmacist in supplementary prescribing, very little has been published that analyses patient outcomes 21, 22 . Studies measuring clinical outcomes of pharmacist prescribing have focused on hypertension, anticoagulation, depression and psychiatry, predominantly in the outpatient setting 23 . These studies had a number of positive patient outcomes, indicating that pharmacist prescribing has the potential to improve treatment outcomes.
The results in this study show that many patients do not receive all medications appropriately. These results are broadly consistent with those reported from other centres. In this study, a pharmacist obtaining and documenting the medication history did not reduce the number of missed doses postoperatively, which varies from many studies in the literature. A possible explanation is that in the hospital where the study was performed, preoperative pharmacist history taking was a new role. Thus there may have been limited awareness by the medical officer charting the medications that a medication history was already documented in the notes.
STUDY STRENGTHS AND LIMITATIONS
A limitation of this study was that intervention groups were unable to be blinded from the patient, pharmacist or the clinicians, introducing the opportunity for bias. It is also recognised that medication history taking post-discharge over the phone is not an ideal method of taking an accurate medication history and may have resulted in medications being omitted from the medication history. For this reason other secondary sources were utilised in prompting the patient to gain as accurate a list as possible. It was also possible that the presence of a pharmacist in the perioperative service highlighted the importance of prescribing regular medications for patients. Each of these factors may have artificially improved the results for the control group. It is also important to note that we did not collect reasons for missed doses. In some cases doses were missed despite medication being charted appropriately. In others, medicines may not have been charted for a reason not documented in the medical record.
At the time of the trial, orthopaedic patients seen in the pre-anaesthetic clinic had their medicines prescribed preoperatively by a medical officer. Thus it is unclear if the results of the trial can be applied to this patient group.
This trial evaluated the quality of prescribing based on the assumption that undocumented variations from patients' regular medicines, other than guided by protocol, are usually unintentional and a surrogate marker of suboptimal delivery of care. A much larger trial would be required to prove that this variation translates into clinical differences including increased patient morbidity or mortality. Anecdotally, the medication history interview took about 15 minutes with each patient and a further 10 minutes if these medications were prescribed on the medication chart. It would be beneficial for further studies to examine the time required to undertake these tasks and the cost-effectiveness of pharmacists undertaking this prescribing role preoperatively compared with current methods.
Legislative change would be necessary for supplementary pharmacist prescribing to be incorporated into routine clinical practice. In addition, there must be careful consideration of training requirements to ensure that pharmacists have the knowledge and skill to undertake these roles safely and maintain appropriate standards 24 .
CONCLUSION
In conclusion, this trial confirms that in this hospital, errors in regular medication management are common for patients admitted for elective surgery. This is similar to findings in other hospitals. Improving the accuracy of documentation of patient medication by pharmacist history taking alone results in a reduction of errors. A significantly greater reduction in medication errors is achieved by changing the perioperative process, with incorporation of pharmacist supplementary prescribing into routine patient care.
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